Madrigal Pharmaceuticals (MDGL) Short Interest Ratio & Short Volume $285.50 +3.18 (+1.13%) As of 10:43 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Madrigal Pharmaceuticals Short Interest DataMadrigal Pharmaceuticals (MDGL) has a short interest of 4.00 million shares, representing 23.76% of the float (the number of shares available for trading by the public). This marks a -2.44% decrease in short interest from the previous month. The short interest ratio (days to cover) is 10.7, indicating that it would take 10.7 days of the average trading volume of 367,546 shares to cover all short positions.Current Short Interest4,000,000 sharesPrevious Short Interest4,100,000 sharesChange Vs. Previous Month-2.44%Dollar Volume Sold Short$1.17 billionShort Interest Ratio10.7 Days to CoverLast Record DateMay 15, 2025Outstanding Shares22,203,000 sharesShort Percent of Float23.76%Today's Trading Volume33,069 sharesAverage Trading Volume367,546 sharesToday's Volume Vs. Average9% Short Selling Madrigal Pharmaceuticals? Sign up to receive the latest short interest report for Madrigal Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMDGL Short Interest Over TimeMDGL Days to Cover Over TimeMDGL Percentage of Float Shorted Over Time Madrigal Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20254,000,000 shares $1.17 billion -2.4%23.8%10.7 $291.82 4/30/20254,100,000 shares $1.37 billion +1.7%N/A11 $333.91 4/15/20254,030,000 shares $1.29 billion +0.8%23.9%10.7 $321.10 3/31/20254,000,000 shares $1.32 billion -2.2%23.8%9.9 $331.23 3/15/20254,090,000 shares $1.42 billion +9.1%24.3%10.1 $348.35 2/28/20253,750,000 shares $1.28 billion -1.3%22.3%9.3 $341.27 2/15/20253,800,000 shares $1.28 billion -4.5%22.6%9.8 $337.20 1/31/20253,980,000 shares $1.33 billion -2.5%N/A9.9 $334.80 1/15/20254,080,000 shares $1.12 billion -0.7%N/A8.6 $274.41 12/31/20244,110,000 shares $1.27 billion -13.1%N/A9.8 $308.57 Get the Latest News and Ratings for MDGL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Madrigal Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/15/20244,730,000 shares $1.44 billion +10.5%N/A11.2 $304.50 11/30/20244,280,000 shares $1.40 billion -3.4%N/A10.6 $328.19 11/15/20244,430,000 shares $1.28 billion -2.2%N/A11.3 $288.58 10/31/20244,530,000 shares $1.17 billion +11.9%N/A13.1 $259.34 10/15/20244,050,000 shares $875.49 million +4.9%N/A15.1 $216.17 9/30/20243,860,000 shares $819.17 million +3.5%N/A13.8 $212.22 9/15/20243,730,000 shares $901.91 million -0.8%N/A13.5 $241.80 8/31/20243,760,000 shares $929.21 million +0.3%N/A11.5 $247.13 8/15/20243,750,000 shares $916.88 million +1.9%N/A9.5 $244.50 7/31/20243,680,000 shares $1.05 billion -10.5%N/A8.6 $284.66 7/15/20244,110,000 shares $1.15 billion +0.7%N/A9.1 $279.95 6/30/20244,080,000 shares $1.14 billion -7.9%N/A9.1 $280.16 6/15/20244,430,000 shares $1.23 billion -15.3%N/A9.5 $277.59 5/31/20245,230,000 shares $1.24 billion +25.4%N/A9.4 $236.16 5/15/20244,170,000 shares $882.91 million +4.8%N/A8.1 $211.73 4/30/20243,980,000 shares $812.00 million +16.7%N/A6.9 $204.02 4/15/20243,410,000 shares $788.97 million +1.5%N/A5.9 $231.37 3/31/20243,360,000 shares $897.25 million +3.1%N/A6 $267.04 3/15/20243,260,000 shares $881.41 million -5.8%20.2%5.9 $270.37 2/29/20243,460,000 shares $817.25 million +2.1%21.4%7.3 $236.20 2/15/20243,390,000 shares $753.33 million +8.0%21.1%7.6 $222.22 1/31/20243,140,000 shares $680.47 million -5.1%19.5%7.2 $216.71 1/15/20243,310,000 shares $780.50 million +1.9%21.1%8.6 $235.80 12/31/20233,250,000 shares $751.99 million +5.9%20.7%7.9 $231.38 12/15/20233,070,000 shares $727.99 million -11.5%19.5%6.7 $237.13 11/30/20233,470,000 shares $705.45 million +0.3%24.4%7.1 $203.30 11/15/20233,460,000 shares $559.41 million +1.5%24.3%7.7 $161.68 10/31/20233,410,000 shares $448.01 million +13.3%24.7%8.2 $131.38 10/15/20233,010,000 shares $422.51 million +13.6%21.8%7.6 $140.37 9/30/20232,650,000 shares $387.01 million +24.4%19.2%7.4 $146.04"Elon’s #1 AI Stock” SET TO SOAR (Ad)Because Elon Musk's AI promises to be 100x more powerful. After all, ChatGPT just works online... While Elon's AI works in the real world."Elon's #1 AI Stock" SET TO SOAR - Get all the details here >>> 9/15/20232,130,000 shares $374.65 million +8.7%16.5%6.3 $175.89 8/31/20231,960,000 shares $352.80 million +8.3%15.2%6.3 $180.00 8/15/20231,810,000 shares $315.25 million -1.1%14.0%5.7 $174.17 7/31/20231,830,000 shares $375.70 million -3.2%13.8%5.3 $205.30 7/15/20231,890,000 shares $426.71 million +7.4%14.3%5.4 $225.77 6/30/20231,760,000 shares $406.56 million +10.0%13.3%4.7 $231.00 6/15/20231,600,000 shares $408.85 million +10.3%12.1%4.7 $255.53 5/31/20231,450,000 shares $403.69 million +15.1%10.4%3.9 $278.41 5/15/20231,260,000 shares $365.77 million -8.7%9.0%3.1 $290.29 4/30/20231,380,000 shares $430.56 million -6.8%10.0%3.3 $312.00 4/15/20231,480,000 shares $354.89 million +19.4%10.8%3.7 $239.79 3/31/20231,240,000 shares $300.40 million +3.3%9.2%3.1 $242.26 3/15/20231,200,000 shares $286.57 million +16.5%8.7%2.3 $238.81 2/28/20231,030,000 shares $279.14 million +9.2%7.4%1.6 $271.01 2/15/2023942,900 shares $266.14 million 0.0%7.2%1.5 $282.26 1/31/2023943,300 shares $271.91 million -3.3%7.2%1.6 $288.25 1/15/2023975,300 shares $292.57 million -12.9%7.5%1.6 $299.98 12/30/20221,120,000 shares $325.08 million -52.7%9.0%1.9 $290.25 12/15/20222,370,000 shares $149.07 million +9.7%19.1%4.3 $62.90 11/30/20222,160,000 shares $151.44 million +3.9%17.4%7.3 $70.11 11/15/20222,080,000 shares $146.68 million +14.3%16.8%7.9 $70.52 10/31/20221,820,000 shares $128.89 million +17.4%14.7%7.4 $70.82 10/15/20221,550,000 shares $100.27 million +1.3%12.5%6.6 $64.69 9/30/20221,530,000 shares $99.43 million +2.7%12.4%7.2 $64.99 9/15/20221,490,000 shares $103.70 million +1.4%12.1%7.4 $69.60 8/31/20221,470,000 shares $106.02 million -4.6%11.9%7.8 $72.12 8/15/20221,540,000 shares $118.13 million -3.8%12.5%8.6 $76.71 7/31/20221,600,000 shares $100.51 million +3.2%12.9%8.4 $62.82 7/15/20221,550,000 shares $107.24 million -4.3%12.5%8.1 $69.19 6/30/20221,620,000 shares $115.96 million -2.4%13.1%8.1 $71.58 6/15/20221,660,000 shares $112.71 million +3.8%13.4%8.6 $67.90 5/31/20221,600,000 shares $106.22 million -5.3%12.9%8.5 $66.39 5/15/20221,690,000 shares $111.08 million -2.9%13.6%8.8 $65.73 4/30/20221,740,000 shares $121.80 million +1.8%14.0%8.2 $70.00 4/15/20221,710,000 shares $135.89 million -5.5%13.8%7.3 $79.47 3/31/20221,810,000 shares $177.60 million -9.1%14.6%7.8 $98.12 3/15/20221,990,000 shares $179.10 million +0.5%16.0%8.5 $90.00 2/28/20221,980,000 shares $183.84 million -1.5%16.0%8.1 $92.85 2/15/20222,010,000 shares $180.72 million +12.3%16.2%8.4 $89.91 1/31/20221,790,000 shares $103.07 million +19.3%14.4%8.5 $57.58 1/15/20221,500,000 shares $117.68 million +8.7%12.1%9.4 $78.45 12/31/20211,380,000 shares $116.94 million -6.8%11.1%9.6 $84.74 12/15/20211,480,000 shares $110.82 million +7.3%11.9%10.8 $74.88 11/30/20211,380,000 shares $114.14 million +2.2%12.0%12 $82.71 11/15/20211,350,000 shares $122.00 million -3.6%11.8%12.7 $90.37 10/29/20211,400,000 shares $108.85 million +3.7%12.2%13.3 $77.75 10/15/20211,350,000 shares $116.33 million -6.9%12.1%13.5 $86.17 9/30/20211,450,000 shares $115.70 million No Change13.0%14.1 $79.79 9/15/20211,450,000 shares $115.10 million -7.1%13.0%11.9 $79.38 8/31/20211,560,000 shares $129.09 million -5.5%14.0%12.2 $82.75"Elon’s #1 AI Stock” SET TO SOAR (Ad)Because Elon Musk's AI promises to be 100x more powerful. After all, ChatGPT just works online... While Elon's AI works in the real world."Elon's #1 AI Stock" SET TO SOAR - Get all the details here >>> 8/13/20211,650,000 shares $140.02 million +3.1%14.8%10.9 $84.86 7/30/20211,600,000 shares $139.71 million -4.2%14.4%10.4 $87.32 7/15/20211,670,000 shares $157.95 million No Change15.0%11 $94.58 6/30/20211,670,000 shares $162.67 million -5.1%15.0%10.9 $97.41 6/15/20211,760,000 shares $185.66 million -7.9%15.8%12.4 $105.49 5/28/20211,910,000 shares $214.49 million -7.3%17.2%14.1 $112.30 5/14/20212,060,000 shares $271.12 million +1.0%18.9%16.5 $131.61 4/30/20212,040,000 shares $280.68 million -8.5%18.7%14.8 $137.59 4/15/20212,230,000 shares $269.70 million -5.1%21.8%12.3 $120.94 3/31/20212,350,000 shares $273.80 million -4.5%23.4%12.7 $116.51 3/15/20212,460,000 shares $289.89 million -7.5%24.5%12.4 $117.84 2/26/20212,660,000 shares $327.34 million -4.0%26.5%13.5 $123.06 2/12/20212,770,000 shares $334.67 million +5.3%28.6%14.4 $120.82 1/29/20212,630,000 shares $304.11 million -8.4%26.0%13.7 $115.63 1/15/20212,870,000 shares $327.18 million +4.7%28.4%17.9 $114.00 12/31/20202,740,000 shares $304.47 million +12.3%27.1%19.3 $111.12 12/15/20202,440,000 shares $294.58 million -2.4%24.2%17.2 $120.73 11/30/20202,500,000 shares $297.78 million +5.5%24.8%16.9 $119.11 11/15/20202,370,000 shares $303.57 million -4.4%23.5%16.3 $128.09 10/30/20202,480,000 shares $318.23 million +0.8%24.6%18.5 $128.32 10/15/20202,460,000 shares $312.94 million No Change24.4%19.1 $127.21 9/30/20202,460,000 shares $292.08 million -13.7%24.4%19.4 $118.73 9/15/20202,850,000 shares $304.72 million +2.5%28.3%21.4 $106.92 8/31/20202,780,000 shares $299.41 million -1.8%27.6%25 $107.70 8/14/20202,830,000 shares $301.37 million +0.4%32.6%24.3 $106.49 7/31/20202,820,000 shares $289.36 million +0.7%32.6%18.9 $102.61 7/15/20202,800,000 shares $291.00 million -4.8%32.4%16.4 $103.93 6/30/20202,940,000 shares $302.06 million +1.0%34.1%14.9 $102.74 6/15/20202,910,000 shares $314.43 million +1.8%33.7%13.9 $108.05 MDGL Short Interest - Frequently Asked Questions What is Madrigal Pharmaceuticals' current short interest? Short interest is the volume of Madrigal Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 4,000,000 shares of MDGL short. 23.76% of Madrigal Pharmaceuticals' shares are currently sold short. Learn More on Madrigal Pharmaceuticals' current short interest. What is a good short interest ratio for Madrigal Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MDGL shares currently have a short interest ratio of 11.0. Learn More on Madrigal Pharmaceuticals's short interest ratio. Which institutional investors are shorting Madrigal Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Madrigal Pharmaceuticals: Jane Street Group LLC, 683 Capital Management LLC, Cubist Systematic Strategies LLC, Caption Management LLC, Twin Tree Management LP, Susquehanna International Group LLP, HAP Trading LLC, Jane Street Group LLC, Walleye Trading LLC, Walleye Capital LLC, Citigroup Inc., and Sivik Global Healthcare LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Madrigal Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 23.76% of Madrigal Pharmaceuticals' floating shares are currently sold short. Is Madrigal Pharmaceuticals' short interest increasing or decreasing? Madrigal Pharmaceuticals saw a decline in short interest in May. As of May 15th, there was short interest totaling 4,000,000 shares, a decline of 2.4% from the previous total of 4,100,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Madrigal Pharmaceuticals' short interest compare to its competitors? 23.76% of Madrigal Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Madrigal Pharmaceuticals: Biogen Inc. (2.28%), United Therapeutics Co. (4.77%), Incyte Co. (4.96%), Neurocrine Biosciences, Inc. (4.22%), Exelixis, Inc. (7.09%), BioMarin Pharmaceutical Inc. (2.38%), Exact Sciences Co. (6.10%), Halozyme Therapeutics, Inc. (8.77%), Repligen Co. (6.40%), Ionis Pharmaceuticals, Inc. (9.83%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($29.20 billion), Strategy Incorporated ($10.88 billion), iShares 20+ Year Treasury Bond ETF ($10.04 billion), Capital One Financial Co. ($5.51 billion), Charter Communications, Inc. ($5.00 billion), Super Micro Computer, Inc. ($4.43 billion), Apollo Global Management, Inc. ($4.02 billion), Hims & Hers Health, Inc. ($3.65 billion), VanEck Semiconductor ETF ($3.27 billion), and Coinbase Global, Inc. ($3.10 billion). View all of the most shorted stocks. What does it mean to sell short Madrigal Pharmaceuticals stock? Short selling MDGL is an investing strategy that aims to generate trading profit from Madrigal Pharmaceuticals as its price is falling. MDGL shares are trading up $2.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Madrigal Pharmaceuticals? A short squeeze for Madrigal Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MDGL, which in turn drives the price of the stock up even further. How often is Madrigal Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MDGL, twice per month. The most recent reporting period available is May, 15 2025. More Short Interest Resources from MarketBeat Related Companies BIIB Short Interest UTHR Short Interest INCY Short Interest NBIX Short Interest EXEL Short Interest BMRN Short Interest EXAS Short Interest HALO Short Interest RGEN Short Interest IONS Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MDGL) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Madrigal Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Madrigal Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MDGL Stock Free MDGL Stock Alerts